IONS:NASDAQ
Ionis Pharmaceuticals Inc
$44.88
arrow_downward
-4.00%(-1.87) 1D
Sep 18, 12:59:17 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
$46.75
High
$46.75
Low
$44.66
Mkt. cap
7.45B
Avg. vol.
3.08M
Volume
1.47M
52-wk high
$86.74
52-wk low
$44.66
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
Open
$46.75
High
$46.75
Low
$44.66
Mkt. cap
7.45B
Avg. vol.
3.08M
Volume
1.47M
52-wk high
$86.74
52-wk low
$44.66
EPS
-$3.47
Beta
0.42
Shares outstanding
166.18M
No. of employees
1K
News stories
From web sources and news partners
Zacks
·
3 hours ago
Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
Investing.com
·
5 hours ago
Ionis stock falls 44% as InvestingPro Fair Value predicted overvaluation By Investing.com
Simply Wall Street
·
16 hours ago
Ionis (IONS) Stock Looks Fully Valued As A Phase 3 Trial Miss Lands
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com